Q3 2024 |
4 |
$154M |
+$238K |
-$69.4M |
-$69.2M |
NU, MRNA, UTI, CART
|
13F-HR |
10/29/2024, 04:26 PM |
Q2 2024 |
3 |
$220M |
$0 |
-$65.8M |
-$65.8M |
NU, MRNA, UTI
|
13F-HR |
8/5/2024, 10:51 AM |
Q1 2024 |
5 |
$270M |
+$7.82M |
-$4.3M |
+$3.51M |
NU, UTI, CPNG, MRNA, U
|
13F-HR |
4/29/2024, 01:16 PM |
Q4 2023 |
4 |
$203M |
+$35.9M |
-$123M |
-$86.8M |
NU, CPNG, UTI, MRNA
|
13F-HR |
1/25/2024, 03:43 PM |
Q3 2023 |
10 |
$278M |
+$31.7M |
-$8.31M |
+$23.4M |
NU, CPNG, LNW, MRNA, DASH
|
13F-HR |
11/9/2023, 10:04 AM |
Q2 2023 |
6 |
$267M |
+$1.18M |
-$189M |
-$188M |
CPNG, NU, LNW, MRNA, SNOW
|
13F-HR |
8/9/2023, 10:41 AM |
Q1 2023 |
11 |
$379M |
+$13.1M |
-$362K |
+$12.7M |
CPNG, LNW, NU, GWRE, MRNA
|
13F-HR |
5/11/2023, 02:21 PM |
Q4 2022 |
7 |
$340M |
+$24.7M |
-$26K |
+$24.7M |
CPNG, LNW, NU, MRNA, GWRE
|
13F-HR |
1/30/2023, 09:24 AM |
Q3 2022 |
7 |
$296M |
+$13.8M |
-$7.22M |
+$6.57M |
CPNG, LNW, NU, MRNA, GWRE
|
13F-HR |
11/14/2022, 09:46 AM |
Q2 2022 |
11 |
$270M |
+$56.7M |
$0 |
+$56.7M |
LNW, CPNG, NU, MRNA, GWRE
|
13F-HR |
8/11/2022, 11:39 AM |
Q1 2022 |
7 |
$277M |
+$16.7M |
-$152K |
+$16.6M |
CPNG, LNW, GWRE, MRNA, MEKA
|
13F-HR |
5/12/2022, 10:34 AM |
Q4 2021 |
6 |
$357M |
+$80.4M |
-$20.5M |
+$59.8M |
CPNG, LNW, MRNA, GWRE, MEKA
|
13F-HR |
2/10/2022, 05:43 PM |
Q3 2021 |
6 |
$344M |
+$83.3M |
-$62.3M |
+$21.1M |
LNW, CPNG, MRNA, GWRE, MEKA
|
13F-HR |
11/12/2021, 10:32 AM |
Q2 2021 |
5 |
$280M |
+$90M |
-$325K |
+$89.7M |
LNW, GWRE, MRNA, DASH, APO
|
13F-HR |
8/13/2021, 11:31 AM |
Q1 2021 |
3 |
$116M |
+$325K |
$0 |
+$325K |
LNW, GWRE, DADA
|
13F-HR |
5/13/2021, 11:11 AM |
Q4 2020 |
2 |
$134M |
$0 |
$0 |
|
LNW, GWRE
|
13F-HR |
2/12/2021, 10:21 AM |